Castle Biosciences, Inc.

Castle Biosciences, Inc.

CSTL
Castle Biosciences, Inc.US flagNASDAQ Global Market
23.90
USD
-0.26
- -
724.73MMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
14
23
52
63
94
137
220
332
344
+ Sales & Services Revenue
14
23
52
63
94
137
220
332
344
- Cost of Revenue
5
5
7
10
16
32
45
60
71
+ Cost of Goods & Services
5
5
7
10
16
32
45
60
71
Gross Profit
9
17
45
53
78
105
175
272
273
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
20
21
37
60
118
196
243
263
316
+ Selling, General & Admin
15
16
30
48
87
143
180
200
229
+ Research & Development
4
5
7
13
30
45
54
52
52
+ Other Operating Expense
- -
- -
- -
-2
2
8
9
11
35
Operating Income (Loss)
-11
-4
7
-7
-40
-91
-68
9
-43
- Non-Operating (Income) Loss
1
3
2
4
- -
-22
-11
-13
-13
+ Interest Expense, Net
2
2
4
2
- -
-4
-11
-12
-12
+ Interest Expense
2
2
5
3
- -
- -
- -
1
- -
- Interest Income
- -
- -
- -
- -
- -
4
11
13
12
+ Other Non-Op (Income) Loss
- -
- -
-2
1
- -
-18
- -
-1
-2
Pretax Income
-12
-6
5
-10
-40
-69
-57
22
-30
- Income Tax Expense (Benefit)
- -
- -
- -
- -
-9
-2
- -
3
-5
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-12
-6
5
-10
-31
-67
-57
18
-24
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-12
-6
5
-10
-31
-67
-57
18
-24
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-12
-6
5
-10
-31
-67
-57
18
-24
- Preferred Dividends
3
4
2
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-15
-10
3
-10
-31
-67
-57
18
-24
EBIT
-11
-4
7
-7
-40
-91
-68
9
-43
EBITDA
-11
-4
8
-6
-37
-81
-56
25
-2
EBITDA Margin (%)
-76.99
-15.42
14.82
-9.69
-38.98
-58.81
-25.32
7.43
-0.59
EBITA
-11
-4
7
-7
-40
-91
-68
9
-43
Gross Margin (%)
64.21
76.75
85.91
84.54
83.18
76.64
79.53
81.87
79.37
Operating Margin (%)
-79.25
-16.83
14.13
-10.44
-42.6
-66.51
-30.93
2.61
-12.44
Profit Margin (%)
-89.93
-27.94
10.17
-16.42
-33.26
-48.99
-26.15
5.49
-7.02
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
3
11
12
16
41
Basic Weighted Avg Shares
10
11
9
19
25
26
27
28
29
Basic EPS, GAAP
-1.56
-0.93
0.36
-0.54
-1.24
-2.58
-2.14
0.66
-0.83
Basic EPS from Cont Ops
-1.26
-0.6
0.61
-0.54
-1.24
-2.58
-2.14
0.66
-0.83
Diluted Weighted Avg Shares
10
11
9
19
25
26
27
29
29
Diluted EPS, GAAP
-1.56
-0.93
0.36
-0.54
-1.24
-2.58
-2.14
0.62
-0.83
Diluted EPS from Cont Ops
-1.26
-0.6
0.61
-0.54
-1.24
-2.58
-2.14
0.62
-0.83

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
7
18
117
430
354
292
296
360
361
+ Cash, Cash Equivalents & STI
1
4
99
410
330
259
243
293
300
+ Cash & Cash Equivalents
1
4
99
410
330
123
99
120
117
+ ST Investments
- -
- -
- -
- -
- -
136
144
173
183
+ Accounts & Notes Receiv
5
12
15
13
17
23
38
51
43
+ Accounts Receivable, Net
5
12
15
13
17
23
38
51
43
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
1
1
2
2
4
8
8
10
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
1
1
2
2
4
8
8
10
+ Other ST Assets
1
1
2
5
5
6
6
8
8
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
3
4
3
10
109
155
158
171
217
+ Property, Plant & Equip, Net
1
2
2
7
17
26
38
63
112
+ Property, Plant & Equip
2
2
3
9
20
34
46
76
131
- Accumulated Depreciation
1
1
1
2
3
8
8
13
18
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
2
3
1
3
92
129
120
108
105
+ Total Intangible Assets
- -
- -
- -
- -
89
126
117
106
100
+ Goodwill
- -
- -
- -
- -
- -
11
11
11
11
+ Other Intangible Assets
- -
- -
- -
- -
89
116
107
96
89
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
2
3
1
3
3
2
3
2
6
Total Assets
10
22
120
439
463
447
453
531
579
+ Payables & Accruals
2
2
3
4
7
9
16
12
25
+ Accounts Payable
1
1
2
2
3
5
10
7
19
+ Accrued Taxes
- -
- -
- -
- -
1
- -
- -
1
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
1
2
2
4
4
5
4
6
+ ST Debt
1
- -
6
- -
1
2
1
2
2
+ ST Borrowings
1
- -
6
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
1
2
1
2
1
+ Other ST Liabilities
3
5
6
17
17
26
30
36
42
+ Deferred Revenue
- -
- -
- -
7
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
3
5
6
10
17
26
30
36
42
Total Current Liabilities
5
7
15
21
25
36
48
49
69
+ LT Debt
18
24
19
- -
7
12
14
24
35
+ LT Borrowings
18
24
19
- -
- -
- -
- -
10
10
+ LT Finance Leases
- -
- -
- -
- -
7
12
14
15
26
+ Other LT Liabilities
1
1
- -
3
19
- -
- -
2
4
+ Accrued Liabilities
- -
- -
- -
2
1
- -
- -
2
2
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
1
1
- -
1
18
- -
- -
- -
2
Total Noncurrent Liabilities
19
26
19
3
26
12
14
26
39
Total Liabilities
24
32
35
24
51
48
62
75
108
+ Preferred Equity and Hybrid Capital
36
46
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
1
137
478
506
560
610
656
695
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
1
137
478
505
560
609
656
695
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-51
-57
-52
-62
-94
-161
-218
-200
-224
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-14
-10
85
416
412
399
391
456
471
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-14
-10
85
416
412
399
391
456
471
Total Liabilities & Equity
10
22
120
439
463
447
453
531
579
Shares Outstanding
15
15
17
25
25
27
27
28
30
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
8
13
15
16
27
Net Debt
17
20
-74
-410
-330
-123
-99
-110
-107
Net Debt to Equity
-121.86
-198.82
-86.62
-98.6
-80.06
-30.8
-25.26
-24.06
-22.65
Tangible Common Equity Ratio
-514.82
-252.53
71.08
94.62
86.4
84.99
81.53
82.26
77.52
Current Ratio
1.28
2.69
7.63
20.58
14.21
8.09
6.2
7.29
5.26
Cash Conversion Cycle
- -
95.2
68.03
77.11
52.92
49.4
43.74
46.05
33.5

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-12
-6
5
-10
-31
-67
-57
18
-24
+ Depreciation & Amortization
- -
- -
- -
- -
3
11
12
16
41
+ Non-Cash Items
- -
1
1
11
13
15
46
45
34
+ Stock-Based Compensation
- -
- -
1
8
22
36
51
50
46
+ Deferred Income Taxes
- -
- -
- -
- -
-9
-2
- -
1
-6
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
- -
2
- -
-19
-5
-7
-6
+ Chg in Non-Cash Work Cap
-1
-7
- -
9
-4
- -
-7
-14
14
+ (Inc) Dec in Accts Receiv
- -
-8
-1
2
-5
-6
-15
-13
7
+ (Inc) Dec in Inventories
- -
-1
- -
-1
- -
-2
-4
- -
-2
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
6
-8
-1
- -
-1
-1
+ Inc (Dec) in Accts Payable
- -
2
3
4
8
8
12
- -
10
+ Inc (Dec) in Other
- -
- -
- -
-1
- -
1
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-12
-12
7
10
-19
-42
-6
65
64
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
-5
-3
-6
-14
-28
-36
+ Acq of Fixed Prod Assets
- -
- -
-1
-5
-3
-6
-14
-28
-36
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
66
330
- -
- -
- -
- -
- -
+ Increase in Capital Stock
- -
- -
66
330
- -
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
-135
-3
-22
2
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
186
184
191
+ Inc in LT Investment
- -
- -
- -
- -
- -
-135
-189
-206
-189
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
-27
- -
- -
-19
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
-27
- -
- -
-19
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
-63
1
- -
- -
-8
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-1
-5
-67
-167
-16
-50
-60
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
9
5
21
-27
- -
- -
- -
10
- -
+ Cash From Debt
11
5
23
- -
- -
- -
- -
10
- -
+ Repayments of Debt
-2
- -
-2
-27
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
10
1
3
5
2
-2
-4
-7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
9
16
88
306
5
2
-2
6
-7
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-4
3
94
311
-80
-207
-24
21
-3
EBITDA
-11
-4
8
-6
-37
-81
-56
25
-2
EBITDA Margin (%)
-76.99
-15.42
14.82
-9.69
-38.98
-58.81
-25.32
7.43
-0.59
Free Cash Flow
-13
-13
6
5
-22
-47
-19
37
28
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
27
- -
- -
19
Free Cash Flow to Firm
- -
- -
11
- -
- -
- -
- -
37
- -
Free Cash Flow to Equity
- -
- -
-22
-22
-22
-47
-19
46
28
Free Cash Flow per Basic Share
-1.3
-1.18
0.71
0.27
-0.89
-1.81
-0.72
1.32
0.98
Price/Free Cash Flow
- -
- -
37.42
86.97
-69.52
-17.03
72.34
8.37
11.23
Cash Flow to Net Income
0.99
1.93
1.33
-0.96
0.61
0.62
0.1
3.56
-2.66
Capital Expenditures
- -
- -
-1
-5
-3
-6
-14
-28
-36